-+ 0.00%
-+ 0.00%
-+ 0.00%

Adlai Nortye Doses First Patient in Phase 1 Trial of Pan-RAS Inhibitor AN9025 for Solid Tumors

Reuters·02/12/2026 09:00:13

Please log in to view news